✦ LIBER ✦

Tamoxifen treatment failures in hormonally responsive breast cancers correlation with steroid receptors

✍ Scribed by Norman D. Bloom; Jerry H. Fishman

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 430 KB
Volume: 51
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19830401)51:7<1190::aid-cncr2820510704>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correlation of hormone receptors with pa

Correlation of hormone receptors with pathological features in human breast cancer

✍ Rosemary R. Millis 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

Steroid receptors and response to endocr

Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast

✍ Thomas L. Dao; Takuma Nemoto 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Estrogen receptors in breast tumors were assayed in 55 premenopausal women undergoing bilateral oophorectomy and in 120 postmenopausal women undergoing bilateral adrenalectomy for treatment of metastatic breast cancer. The data show that 20 (60%) of the 32 patients with estrogen receptor-positive (E

The value of estrogen and progesterone r

The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen

✍ Werner Robert Bezwoda; Jan D. Esser; Roger Dansey; Ivan Kessel; Myron Lange 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

The use of antiestrogens tamoxifen and n

The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. A phase II study

✍ Dane L. Moseson; Gordon H. Sasaki; William G. Kraybill; Benjamin S. Leung; Charl 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 2 views

Co-expression of tenascin-C and vimentin

Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins

✍ N. Dandachi; C. Hauser-Kronberger; E. Moré; B. Wiesener; G. W. Hacker; O. Dietze 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 1 views

Estrogen receptor (ER) and progesterone

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study

✍ Richard M. Elledge; Stephanie Green; Reginald Pugh; D. Craig Allred; Gary M. Cla 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 133 KB 👁 2 views

Results of estrogen receptor (ER) and progesterone receptor (PgR) ligand-binding assays (LBAs) are strongly correlated with ER and PgR by immuno-histochemistry (IHC). To investigate whether ER and PgR by IHC are also strongly correlated with tamoxifen response, time to treatment failure (TTF) and ov